How many organs could you donate and remain alive? How many planet Earths could fit inside the Sun? How high is a giraffe's blood pressure? Why is the sea blue? To find out, Ask The Naked Scientists!
…
continue reading
Το περιεχόμενο παρέχεται από το Sano Genetics. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Sano Genetics ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
Player FM - Εφαρμογή podcast
Πηγαίνετε εκτός σύνδεσης με την εφαρμογή Player FM !
Πηγαίνετε εκτός σύνδεσης με την εφαρμογή Player FM !
EP 114: The Biggest Stories of 2023 with Dr. Veera Rajagopal (Part 1)
MP3•Αρχική οθόνη επεισοδίου
Manage episode 390778420 series 2631947
Το περιεχόμενο παρέχεται από το Sano Genetics. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Sano Genetics ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
0:00 Introduction
1:30 Veera’s personal highlights of 2023
1:30 Veera’s personal highlights of 2023
- Publication in Nature Genetics: Rare coding variants in CHRNB2 reduce the likelihood of smoking, an exome-wide association study identifying rare coding variants in CHRNB2 that may reduce the likelihood of smoking.
- Designing cover art
- Genetic links to neural circuits and their role in addiction
10:50 The most exciting story of the year: the first successful translation of a GWAS discovery into medicine
- A milestone year in GWAS-driven drug development: FDA Approval of Casgevy, a cell based gene therapy for the BCL11A transcription factor, in the US and UK to treat sickle cell disease
- Strong genetic support for the ongoing development of APOL1 inhibitors to treat kidney disease
- Additional disease modifier variants, including the APOE4 variant in Alzhemer’s Disease
34:52 How rare Mendelian diseases can offer insights into drug developments
- Looping back to BCL11A: how neurodevelopmental disorder patients with BCL11A haploinsufficiency provided insights into sickle cell treatment
- BCL11A knockdown to induce fetal hemoglobin production and alleviate sickle cell disease
- Recessive mutations in HMGCR provide the missing link into why statins can induce myopathy. Learn more in this Atlantic article.
- The often underappreciated importance of studying rare Mendelian diseases
51:31 The value of common variants vs rare variants in informing drug targets
- Why are pharmaceutical companies studying rare variants?
- How the FTO locus associated with obesity highlights challenges in identifying causal gene variants
- Surprising twists in translating mice physiology to human physiology, and decades-long quest to understanding the mechanism behind this extremely early GWAS hit
1:00:32 Genetic drift, endogamy, and consanguinity
- The rise of large-scale studies looking beyond European populations
- The FinnGen study: a significant step forward in understanding the genetic basis of diseases in founder populations
- Interesting discoveries from integrating non-European populations in biobanks and Direct to Consumer databases
- A recent 23andMe paper that identifies a founder variant in Puerto Rican populations associated with a strong risk effect on cataract development
1:13:40 Concluding remarks and looking ahead to Part 2!
Check out Veera's substack, GWAS Stories, and follow him on Twitter, @doctorveera
179 επεισόδια
MP3•Αρχική οθόνη επεισοδίου
Manage episode 390778420 series 2631947
Το περιεχόμενο παρέχεται από το Sano Genetics. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Sano Genetics ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
0:00 Introduction
1:30 Veera’s personal highlights of 2023
1:30 Veera’s personal highlights of 2023
- Publication in Nature Genetics: Rare coding variants in CHRNB2 reduce the likelihood of smoking, an exome-wide association study identifying rare coding variants in CHRNB2 that may reduce the likelihood of smoking.
- Designing cover art
- Genetic links to neural circuits and their role in addiction
10:50 The most exciting story of the year: the first successful translation of a GWAS discovery into medicine
- A milestone year in GWAS-driven drug development: FDA Approval of Casgevy, a cell based gene therapy for the BCL11A transcription factor, in the US and UK to treat sickle cell disease
- Strong genetic support for the ongoing development of APOL1 inhibitors to treat kidney disease
- Additional disease modifier variants, including the APOE4 variant in Alzhemer’s Disease
34:52 How rare Mendelian diseases can offer insights into drug developments
- Looping back to BCL11A: how neurodevelopmental disorder patients with BCL11A haploinsufficiency provided insights into sickle cell treatment
- BCL11A knockdown to induce fetal hemoglobin production and alleviate sickle cell disease
- Recessive mutations in HMGCR provide the missing link into why statins can induce myopathy. Learn more in this Atlantic article.
- The often underappreciated importance of studying rare Mendelian diseases
51:31 The value of common variants vs rare variants in informing drug targets
- Why are pharmaceutical companies studying rare variants?
- How the FTO locus associated with obesity highlights challenges in identifying causal gene variants
- Surprising twists in translating mice physiology to human physiology, and decades-long quest to understanding the mechanism behind this extremely early GWAS hit
1:00:32 Genetic drift, endogamy, and consanguinity
- The rise of large-scale studies looking beyond European populations
- The FinnGen study: a significant step forward in understanding the genetic basis of diseases in founder populations
- Interesting discoveries from integrating non-European populations in biobanks and Direct to Consumer databases
- A recent 23andMe paper that identifies a founder variant in Puerto Rican populations associated with a strong risk effect on cataract development
1:13:40 Concluding remarks and looking ahead to Part 2!
Check out Veera's substack, GWAS Stories, and follow him on Twitter, @doctorveera
179 επεισόδια
Alle episoder
×Καλώς ήλθατε στο Player FM!
Το FM Player σαρώνει τον ιστό για podcasts υψηλής ποιότητας για να απολαύσετε αυτή τη στιγμή. Είναι η καλύτερη εφαρμογή podcast και λειτουργεί σε Android, iPhone και στον ιστό. Εγγραφή για συγχρονισμό συνδρομών σε όλες τις συσκευές.